US patent strategy will jeopadize domestic pharmaceutical industry

Published: 2006-08-21 07:00:00

Updated: 2006-08-21 07:00:00

"Strengthening patents of original drugs, which has been sought by the United States in the free trade agreement talks, will deal a serious blow to the local pharmaceutical industry as the newly developed medicines will likely a dominate the local market. This will give bigger grants to the U.S. ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK